The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients [5]

Nephrology Dialysis Transplantation

Volumn 14, Issue 8, 1999, Pages 2047-2049

  Chew, C G ^a   Weise, M D ^a   Disney, A P S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN; RECOMBINANT ERYTHROPOIETIN;

CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; RECEPTORS, ANGIOTENSIN; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 0032787799     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.8.2047     Document Type: Letter

References (14)